Life Science Leader Magazine Supplements

CRO Leadership Awards 2014

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link:

Contents of this Issue


Page 29 of 45

QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M 2014 CRO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2014 28 SERVICES & CAPABILITIES: inVentiv Health Clinical is a leading provider of global drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies, offering therapeutically specialized capabilities for Phas e I-IV clinical development, bioanalytical services, and strategic resourcing from a single clinical professional to an entire functional team. THERAPEUTIC AREAS: inVentiv Health Clinical has expertise in virtually all therapeutic areas, including CNS, cardiovascular, dermatology, endocrinology and metabolics, immunology, infectious diseases, nephrology, oncology, pain and inflammatory d isease. "inVentiv Health Clinical is a top-tier global CRO with a unique perspective. As part of inVentiv Health, we offer a comprehensive range of integrated clinical, commercial, and consulting services that can move a promising product from clinical development through commercialization. At our core, we are a company of extremely talented and experienced individuals with much to offer — and we are appreciative of our clients' recognition for this year's CRO Leadership Awards." SERVICES & CAPABILITIES: Bioanalytical testing, biomarkers, biorepository services, companion diagnostics, cytogenetics, early phase and regional capabilities, endocrinology, flow cytometry, infectious disease and viral genotyping, in vitro diagnostic device clinical trials, method development and validation in addition to global central safety testing for all your protocols. THERAPEUTIC AREAS: LabCorp Clinical Trials provides full-service laboratory testing at wholly- owned central labs in Belgium, China, Singapore, and the U.S., including Phase I-IV trials, esoteric testing, biomarker development, and companion diagnostics. "LabCorp Clinical Trials is honored to receive this special recognition from our clients in the four categories of reliability, innovation, productivity, and regulatory. This distinction spotlights our dedicated employees who make a difference for our clients each and every day. Our organization is committed to providing exemplary quality in every aspect of our business. We focus not only on the service we provide today, but also on the new and innovative solutions we will provide tomorrow. We appreciate your trust and will work tirelessly to keep it." SERVICES & CAPABILITIES: Regulated bioanalysis (method development, GLP validation, and sample analysis for small molecules, macromolecules, and biomarkers), DMPK assays, metabolic stability, metabolite profiling & identification, CYP/UGT induction, inhibition & identification, pharmacokinetic analysis THERAPEUTIC AREAS: Provide regulated bioanalysis, drug metabolism, and pharmacokinetic analysis services for all therapeutic areas "For more than 15 years, MicroConstants has aimed to function as an extension of our sponsors' development teams. Constant communication and active participation in our sponsors' programs has enabled us to suggest critical solutions to their analytical challenges, and anticipate their needs. We are so honored that our sponsors have acknowledged our efforts, and awa rded us with high marks in the regulatory, quality, and innovation categories." DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3, Phase 4) DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) MAIN SERVICE AREAS: Bioanalytical, Clinical MAIN SERVICE AREAS: Bioanalytical, Clinical MAIN SERVICE AREAS: Bioanalytical, Clinical, Preclinical DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) RAY HILL president STEVE ANDERSON, PH.D. SV P and global head of clinical trials GILBERT N. LAM, PH.D. president CATEGORIES WON CATEGORIES WON: CATEGORIES WON MicroConstants San Diego, CA +1 858 652 4600 Ron Shevock Key locations: Beijing, China and San Diego, CA LabCorp Clinical Trials Cranford, NJ +1 877 788 8861 Josh Goldsmith, Ph.D. Key locations: Beijing, China; Brentwood, TN; Cranford, NJ; Durham, NC; Hollywood, FL; Los Angeles, CA; U.S.A.; Mechelen, Belgium; Singapore inVentiv Health Clinical Princeton, NJ +1 609 951 6800 Greg Skalicky, EVP Business Development Key locations: Ann Arbor, MI; Buenos Aires, Argentina; Maidenhead, U.K.; Princeton, NJ; Quebec City, Quebec, Canada; Singapore; Zurich, Switzerland 2 0 1 4 L S L C R O C o m p a n y P r o f i l e L a y o u t T h a t N i c e . i n d d 1 0 2014 LSL CRO Company Profile Layout That Nice.indd 10 2 / 2 4 / 2 0 1 4 8 : 3 1 : 1 5 A M 2/24/2014 8:31:15 AM

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2014